Establishing the level of safety concern for chemicals in food without the need for toxicity testing

Regulatory Toxicology and Pharmacology

Volumn 68, Issue 2, 2014, Pages 275-296

  Schilter, Benoît ^a   Benigni, Romualdo ^b   Boobis, Alan ^c   Chiodini, Alessandro ^d   Cockburn, Andrew ^e   Cronin, Mark T D ^f   Lo Piparo, Elena ^a   Modi, Sandeep ^g   Thiel, Anette ^h   Worth, Andrew ⁱ  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d International Life Sciences Institute of Europe   (Belgium)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^g UNILEVER RESEARCH   (United Kingdom)

^h DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

ⁱ JOINT RESEARCH CENTRE   (Italy)

Author keywords

(Q)SAR; Chemical grouping; Food; In silico toxicology; Incident management; Predictive toxicology; Read across; Risk assessment; Uncertainties

Indexed keywords

(Q)SAR; CHEMICAL GROUPING; FOOD; IN SILICO TOXICOLOGY; INCIDENT MANAGEMENT; PREDICTIVE TOXICOLOGY; READ ACROSS; RISK ASSESSMENT; UNCERTAINTIES;

ANIMALS; COMPUTER SIMULATION; DECISION TREES; FOOD; FOOD SAFETY; HUMANS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RISK ASSESSMENT; SOFTWARE;

EID: 84893796902     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2013.08.018     Document Type: Article

References (109)

1. AEGL, 2001. Standing operation procedures for developing acute exposure guideline levels for hazardous chemicals. Available at: http://www.epa.gov/opptintr/aegl/pubs/sop.pdf.
2. Ankley G.T., Bennett R.S., Erickson R.J., Hoff D.J., Hornung M.W., Johnson R.D., Mount D.R., Nichols J.W., Russom C.L., Schmieder P.K., Serrano J.A., Tietge J.E., Villeneuve D.L. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem. 2010, 29(3):730-741.
3. Bai J.P.F., Utis A., Crippen G., He H.D., Fischer V., Tullman R., Yin H.Q., Hsu C.P., Jiang L., Hwang K.K. Use of classification regression tree in predicting oral absorption in humans. J. Chem. Inf. Comput. Sci. 2004, 44:2061-2069.
4. Batke M., Escher S., Hoffmann-Doerr S., Melber C., Messinger H., Mangelsdorf I. Evaluation of time extrapolation factors based on the database RepDose. Toxicol. Lett. 2011, 205:122-129.
5. Benfenati E., Benigni R., Marini D., Helma C., Kirkland D., Martin T.M., Mazzatorta P., Meunier J.-R., Ouédraogo-Arras G., Richard A., Schilter B., Schoonen W.G.E.J., Snyder R., Yang C., Youne D.M. Predictive models for carcinogenicity and mutagenicity. Frameworks, state-of-the art and perspectives. J. Environ. Sci. Health Part C 2009, 27:57-90.
6. Benigni R., Bossa C., Netzeva T., Rodomonte A., Tsakovska I. Mechanistic QSAR of aromatic amines: new models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens. Environ. Mol. Mutag. 2007, 48:754-771.
7. Benigni R., Netzeva T.I., Benfenati E., Bossa C., Franke R., Helma C., Hulzebos E., Marchant C., Richard A., Woo Y.T., Yang C. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens. J. Environ. Sci. Health. C. Environ. Carcinog. Ecotoxicol. 2007, 25(1):53-97.
8. Benigni R., Bossa C., Alivernini S., Colafranceschi M. Assessment and validation of US EPA's oncologic expert system and analysis of its modulating factors for structural alerts. J. Environ. Sci. Health Part C 2012, 30:152-173.
9. Bercu J.P., Morton S.M., Deahl J.T., Gombar V.K., Callis C.M., van Lier R.B. In silico approaches to predicting cancer potency for risk assessment of genotoxic impurities in drug substances. Regul. Toxicol. Pharmacol. 2010, 57(2):300-306.
10. Bitsch A., Jacobi S., Melber C., Wahnschaffe U., Simetska N., Mangelsdorf I. REPDOSE: a database on repeated dose toxicity studies of commercial chemicals. A multifunctional tool. Regul. Toxicol. Pharmacol. 2006, 46:202-210.
11. Blackburn K., Bjerke D., Daston G., Felter S., Mahony C., Naciff J., Robison S., Wu S. Case studies to test: a framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments. Regul. Toxicol. Pharmacol. 2011, 60:120-135.
12. Bokkers B.G., Slob W. A comparison of ratio distributions based on the NOAEL and the benchmark approach for subchronic-to-chronic extrapolation. Toxicol. Sci. 2005, 85(2):1033-1040.
13. Bos P.M.J., Baars B.J., van Raaij M.T.M. Risk assessment of peak exposure to genotoxic carcinogens: a pragmatic approach. Toxicol. Lett. 2004, 151:43-50.
14. Boyer S., Arnby C.H., Carlsson L., Smith J., Stein V., Glen R.C. Reaction site mapping of xenobiotic biotransformations. J. Chem. Inf. Model. 2007, 47:583-590.
15. Callis C.M., Bercu J.P., DeVries K.M., Dow L.K., Robbins D.K., Varie D.L. Risk assessment of genotoxic impurities in marketed compounds administered over a short-term duration: applications to oncology products and implications for impurity control limits. Org. Process Res. Dev. 2010, 14:986-992.
16. Clark D.E. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. J. Pharm. Sci. 1999, 88:807-814.
17. Contrera J.F. Improved in silico prediction of carcinogenic potency (TD50) and the risk specific dose (RSD) adjusted threshold of toxicological concern (TTC) for genotoxic chemicals and pharmaceutical impurities. Regul. Toxicol. Pharmacol. 2011, 59(1):133-141.
18. Contrera J.F., Matthews E.J., Kruhlak N.L., Benz R.D. Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose. Regul. Toxicol. Pharmacol. 2004, 40(3):185-206.
19. COT (Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment), 2007. Variability and uncertainty in toxicology of chemicals in food, consumer products and the environment. 2007. http://www.cot.food.gov.uk/pdfs/vutreportmarch2007.pdf.
20. Cotterill J.V., Chaudhry M.Q., Matthews W., Watkins R.W. In silico assessment of toxicity of heat-generated food contaminants. Food Chem. Toxicol. 2008, 46(6):1905-1918.
21. Cronin M.T.D. The prediction of skin permeability using quantitative structure-activity relationships (QSARs). Dermal Absorption Models in Toxicology and Pharmacology 2005, 113-134. CRC Press, Boca Raton, FL, USA. J.E. Riviere (Ed.).
22. Cronin M.T.D. In silico toxicology challenges for pharmaceuticals: complacency or controversy?. ATLA 2009, 37:453-456.
23. Cronin M.T.D. Prediction of harmful human health effects of chemicals from structure. Recent Advances in QSAR Studies - Methods and Applications 2010, 305-325. Springer, Dordrecht. T. Puzyn, J. Leszczynski, M.T.D. Cronin (Eds.).
24. Cronin M.T.D. In silico tools for toxicity prediction. New Horizons in Predictive Toxicology: Current Status and Application 2011, 9-25. The Royal Society of Chemistry, Cambridge. A.G.E. Wilson (Ed.).
25. Cruciani G., Carosati E., De Boeck B., Ethirajulu K., Mackie C., Howe T., Vianello R. MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. J. Med. Chem. 2005, 48:6970-6979.
26. ECB, 2003. Technical guidance document on risk assessment in support of commission directive 93/67/EEC etc. Part I, document is available at: http://www.ihcp.jrc.ec.europa.eu/our_activities/health-env/risk_assessment_of_Biocides/doc/tgd/tgdpart1_2ed.pdf.
27. ECETOC, 2010. Guidance on assessment factors to derive a DNEL, technical report No 110, ISSN-0773-8072-110, October 2010. http://www.members.ecetoc.org/Documents/Document/20110131112906-ECETOC_Technical_Report_110.pdf.
28. ECHA, 2008. REACH guidance on information requirements and chemical safety assessment Chapter R.8: characterisation of dose [concentration]-response for human health. http://www.echa.europa.eu/documents/10162/13632/information_requirements_r8_en.pdf.
29. EFSA Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food on a request from the commission related to 2-isopropyl thioxanthone (ITX) and 2-ethylhexyl-4-dimethylaminobenzoate (EHDAB) in food contact materials. EFSA J. 2005, 293:1-15. .
30. EFSA Opinion of the scientific committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic. EFSA J. 2005, 282:1-31. .
31. EFSA Opinion on 2-isopropyl thioxanthone (ITX) and 2-ethylhexyl-4-dimethylaminobenzoate (EHDAB) in food contact materials. EFSA J. 2005, 293:1-15. .
32. EFSA Guidance of the scientific committee on a request from EFSA related to uncertainties in dietary exposure assessment. EFSA J. 2006, 438:1-54. .
33. EFSA An update on the hazard assessment of 2-isopropyl thioxanthone (ITX) in food contact materials. EFSA Statement 2007, .
34. EFSA Use of the benchmark dose approach in risk assessment. EFSA J. 2009, 1150:1-72. .
35. EFSA Guidance on selected default values to be used by the EFSA Scientific Committee, Scientific Panels and Units in the absence of actual measured data. EFSA J. 2012, 10:2579. .
36. EMA, 2009. ICH topic Q3C (R4) impurities: guideline for residual solvents. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002674.pdf.
37. EMA, 2010. European Medicines Agency, EMA/CHMP/SWP/431994/2007 Rev. 3, dated 23-September-2010. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002907.pdf.
38. Enoch S.J., Cronin M.T.D. A review of the electrophilic reaction chemistry involved in covalent DNA binding. Crit. Rev. Toxicol. 2010, 40:724-748.
39. Enoch S.J., Cronin M.T., Schultz T.W., Madden J.C. Quantitative and mechanistic read across for predicting the skin sensitization potential of alkenes acting via Michael addition. Chem. Res. Toxicol. 2008, 21(2):513-520.
40. EuPIA, 2011. Inventory list comprising of packaging ink raw materials applied to the non-food contact surface of food packaging. European Printing Ink Association, list version January 2011. http://www.eupia.org/EPUB/easnet.dll/ExecReq/Page?eas:template_im=10008E%26eas:dat_im=05048E.
41. FDA Guidance for industry estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Pharmacol. Toxicol. 2005, fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm078932.pdf>.
42. FDA Guidance for industry genotoxic and carcinogenic impurities in drug substances and products: recommended approaches. Pharmacol. Toxicol. 2008, pp. 8-11.
43. Felter S.P., Conolly R.B., Bercu J.P., Bolger P.M., Boobis A.R., Bos P.M., Carthew P., Doerrer N.G., Goodman J.I., Harrouk W.A., Kirkland D.J., Lau S.S., Llewellyn G.C., Preston R.J., Schoeny R., Schnatter A.R., Tritscher A., van Velsen F., Williams G.M. A proposed framework for assessing risk from less-than-lifetime exposures to carcinogens. Crit. Rev. Toxicol. 2011, 41(6):507-544.
44. Fourches D., Muratov E., Tropsha A. Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modelling research. J. Chem. Inf. Model. 2010, 50:1189-1204.
45. Fowler, B., Savage, S., Mendez, B., 2011. Protecting public health in the 21st century: the case for computational toxicology. White paper, ICF International, Inc. icfi.com.
46. Gaylor D.W. The use of Haber's law in standard setting and risk assessment. Toxicology 2000, 149(1):17-19.
47. Gaylor D.W., Chen J.J., Sheehan D.M. Uncertainty in cancer risk estimates. Risk Anal. 1993, 13:149-154.
48. Gold L.S., Gaylor D.W., Slone T.H. Comparison of cancer risk estimates based on a variety of risk assessment methodologies. Regul. Toxicol. Pharmacol. 2003, 37:45-53.
49. IPCS Environmental Health Criteria 240: principles and methods for the risk assessment of chemicals in food. Dose-Response Assessment and Derivation of Health-Based Guidance Values 2009, WHO, Geneva, Switzerland, Chapter 5.
50. JECFA, 2010. Pesticide residues in food 2010 REPORT 2010 Joint FAO/WHO Meeting on Pesticide Residues. ISSN 0259-2517. http://www.fao.org/docrep/013/i1949e/i1949e00.pdf.
51. JMPR, 2009. Chlorothalonil. Pesticide residues in food - 2009. Toxicological evaluations. Chlorothalonil 103-154 JMPR 2009. http://www.apps.who.int/iris/bitstream/10665/44522/1/9789241665254_eng.pdf.
52. JMPR, 2010. Chlorothalonil metabolite R611965. Pesticide residues in food 2010. Toxicological evaluations. Chlorothalonil Metabolite R611965 3-18 JMPR 2010. http://www.apps.who.int/iris/bitstream/10665/44660/1/9789241665261_eng.pdf.
53. JRC 2010. Applicability of QSAR analysis to the evaluation of the toxicological relevance of metabolites and degradates of pesticide active substances for dietary risk assessment. Report from the European Commission's Joint Research Centre (JRC) to the European Food Safety Authority (EFSA). Available at: http://www.efsa.europa.eu/en/scdocs/scdoc/50e.htm.
54. Judson P.N. Expert systems. Computational toxicology: risk assessment for pharmaceutical and environmental chemicals 2007, 521-543. Wiley, Hoboken, NJ. S. Ekins (Ed.).
55. Jurgutis P.J., Didziapetris R., Japertas P. Rule-based approach for prediction ofrabbit eye and skin irritation. Chem. Res. Toxicol. 2007, 20.
56. Kalberlah, F., Schneider, K., 1998. Quantification of extrapolation factors: Final report of the research project No. 116 06 113 of the Federal Environmental Agency. Wirtschaftsverlag NW.
57. Kalberlah F., Föst U., Schneider K. Time extrapolation and interspecies extrapolation for locally acting substances in case of limited toxicological data. Ann. Occup. Hyg. 2002, 46(2):175-185.
58. Klimisch H.J., Andreae M., Tillmann U. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul. Toxicol. Pharmacol. 1997, 25:1-5.
59. Klopman G., Stefan L.R., Saiakhov R.D. ADME evaluation. 2. A computer model for the prediction of intestinal absorption in humans. Eur. J. Pharm. Sci. 2002, 17:253-263.
60. Kramers P.G.N., Gentile J.M., Gryseels B.J.A.M., Jordan P., Katz N., Mott K.E., Muvihill J.J., Seed J.L., Frohberg H. Review of the genotoxicity and carcinogenicity of antischistosomal drugs; is there a case for a study of mutation epidemiology? Report of a task group on mutagenic antischistosomals. Mut. Res. 1991, 257:49-89.
61. Kroes R., Renwick A., Cheeseman M., Kleiner J., Mangelsdorf I., Piersma A., Schilter B., Schlatter J., van Schothorst F., Vos J.G., Würtzen G. Structure-based thresholds of toxicological concern: guidance for application to substances present at low levels in the diet. Food Chem. Toxicol. 2004, 42:65-83.
62. Kroes R., Renwick A.G., Feron V., Galli C.L., Gibney M., Greim H., Guy R.H., Lhuguenot J.C., van de Sandt J.J. Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients. Food Chem. Toxicol. 2007, 45(12):2533-2562.
63. Lapenna, S., M., Fuart-Gatnik, Worth, A., 2010. Review of QSAR models and software tools for predicting acute and chronic systemic toxicity. In: Published by European Commission, Joint Research Centre, EUR 24639 EN, 35.
64. Lijinsky W., Taylor H.W. Feeding tests in rats on mixtures of nitrite with secondary and tertiary amines of environmental importance. Food Cosmet. Toxicol. 1977, 15:269-274.
65. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997, 23:3-25.
66. Madden J.C. In silico approaches for predicting ADME properties. Chapter 10 in recent advances in QSAR studies: methods and applications 2010, 283-304. Springer, Heidelberg, Germany. T. Puzyn, J. Leszczynski, M.T.D. Cronin (Eds.).
67. Madden J.C. Toxicokinetic considerations in predicting toxicity. Chapter 21 in in silico toxicology: principles and applications 2010, 531-557. Royal Society of Chemistry, Cambridge, England. M.T.D. Cronin, J.C. Madden (Eds.).
68. Malkiewicz K., Hansson S.O., Ruden C. Assessment factors for extrapolation from short-term to chronic exposure - are the REACH guidelines adequate?. Toxicol. Lett. 2009, 190:16-22.
69. Matthews E.J., Contrera J.F. In silico approaches to explore toxicity endpoints: Issues and concerns for estimating human health effects. Expert Opin. Drug Metabol. Toxicol. 2007, 3:125-134.
70. Matthews E.J., Kruhlak N.L., Weaver J.L., Benz R.D., Contrera J.F. Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current Drug. Disc. Technol. 2004, 1:243-254.
71. Matthews E.J., Kruhlak N.L., Benz R.D., Contrera J.F. Assessment of the health effects of chemicals in humans: I. QSAR estimation of the maximum recommended therapeutic dose (MRTD) and no effect level (NOEL) of organic chemicals based on clinical trial data. Curr. Drug Disc. Technol. 2004, 1:61-76.
72. Maunz A., Helma C. Prediction of chemical toxicity with local support vector regression and activity-specific kernels. SAR QSAR Environ. Res. 2008, 19:413-431.
73. Maunz A., Gütlein M., Rautenberg M., Vorgrimmler D., Gebele D., Helma C. Lazar: a modular predictive toxicology framework. Front. Pharm. 2013, http://dx.doi.org/10.3389/fphar.2013.00038. Published on 11 April 2013.
74. Mazzatorta P., Tran L.A., Schilter B., Grigorov M. Integration of structure-activity relationship and artificial intelligence systems to improve in silico prediction of Ames tetast mutagenicity. J. Chem. Model. 2007, 47:34-38.
75. Mazzatorta P., Estevez M.D., Coulet M., Schilter B. Modeling oral rat chronic toxicity. J. Chem. Inf. Model. 2008, 48(10):1949-1954.
76. Meek M.E., Boobis A.R., Crofton K.M., Heinemeyer G., Raaij M.V., Vickers C. Risk assessment of combined exposure to multiple chemicals: a WHO/IPCS framework. Regul. Toxicol. Pharmacol. 2011, 60:S1-S14.
77. Müller L., Mauthe R.J., Riley C.M., Andino M.M., Antonis D.D., Beels C., DeGeorge J., De Knaep A.G., Ellison D., Fagerland J.A., Frank R., Fritschel B., Galloway S., Harpur E., Humfrey C.D., Jacks A.S., Jagota N., Mackinnon J., Mohan G., Ness D.K., O'Donovan M.R., Smith M.D., Vudathala G., Yotti L. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. Regul. Toxicol. Pharmacol. 2006, 44(3):198-211.
78. Munro I.C., Ford R.A., Kennepohl E., Sprenger J.G. Correlation of structural class with no-observed effect levels: a proposal for establishing a threshold of concern. Food Chem. Toxicol. 1996, 34:829-867.
79. Nendza M., Aldenberg T., Benfenati E., Benigni R., Cronin M.T.D., Escher S., Fernandez A., Gabbert S., Giralt F., Hewitt M., Hrovat M., Jeram S., Kroese D., Madden J.C., Mangelsdorf I., Rallo R., Roncaglioni A., Rorije A., Segner H., Simon-Hettich B., Vermeire T. Data quality assessment for in silico methods: a survey of approaches and needs. In Silico Toxicology: Principles and Applications 2010, 59-117. The Royal Society of Chemistry, Cambridge. M.T.D. Cronin, J.C. Madden (Eds.).
80. Norinder U., Haberlein M. Computational approaches to the prediction of the blood-brain distribution. Adv. Drug Deliv. Rev. 2002, 54:291-313.
81. O'Brien J., Renwick A.G., Constable A., Dybing E., Müller D.J.G., Schlatter J., Slob W., Tueting W., van Benthem J., Williams G.M., Wolfreys A. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal. Food Chem. Toxicol. 2006, 44:1613-1635.
82. OECD, 2007. Guidance on Grouping of Chemicals, OECD Environment Health and Safety Publications, Series on Testing and Assessment No. 80, 2007. http://www.oecd.org/officialdocuments/displaydocument/?doclanguage=en%26cote=env/jm/mono(2007)28.
83. Ong T.M. Genetic activities of hycanthone and some other antischistosomal drugs. Mut. Res. 1978, 55:43-70.
84. Piegorsch W.W., Zeiger E. Measuring Intra-assay Agreement for the Ames Salmonella assay. Lecture Notes in Medical Informatics 1991, Springer-Verlag, Heidelberg, 35-41.
85. Pieters M.N., Kramer H.J., Slob W. Evaluation of the uncertainty factor for subchronic-to-chronic extrapolation: statistical analysis of toxicity data. Regul. Toxicol. Pharmacol. 1998, 27(2):108-111.
86. Pohl H.R., Chou C.H., Ruiz P., Holler J.S. Chemical risk assessment and uncertainty associated with extrapolation across exposure duration. Regul. Toxicol. Pharmacol. 2010, 57(1):18-23.
87. Poroikov V.V., Filimonov D.A., Borodina Yu.V., Lagunin A.A., Kos A. Robustness of biological activity spectra predicting by computer program PASS for non-congeneric sets of chemical compounds. J. Chem. Inform. Comput. Sci. 2000, 40:1349-1355.
88. Przybylak K.R., Hewitt M., Madden J.C., Cronin M.T.D. Assessing toxicological data quality: basic principles, existing schemes and current limitations. Regul. Toxicol. Pharmacol. 2011, http://dx.doi.org/10.1080/1062936X.2012.664825. Available on line since 16 Apr 2012.
89. Renwick A.G., Barlow S.M., Hertz-Picciotto I., Boobis A.R., Dybing E., Edler L., Eisenbrand G., Greig J.B., Kleiner J., Lambe J., Müller D.J.G., Smith M.R., Tritscher A., Tuijtelaars S., van den Brandt P.A., Walker R., Kroes R. Risk characterisation of chemicals in food and diet. Food Chem. Toxicol. 2003, 41:1211-1271.
90. SCHER, SCCS, SCENIHR, 2011. Toxicity assessment of chemical mixtures. Preliminary opinion approved for public consultation. Directorate-General Health and Consumers. http://www.ec.europa.eu/health/scientific_committees/environmental_risks/docs/scher_o_155.pdf.
91. Schneider, K., Hausser, M., Oltmanns, J., Schuhmacher-Woltz, U., Elmshäuser, E., Mosbach-Schultz, O., 2005. Uncertainty analysis in workplace effect assessment. Research Report F 1824, F 1825, F1826. Federal Institute for Occupational Safety and Health (BAuA). http://www.baua.de/en/Publications/Expert-Papers/Gd36.html.
92. Schneider K., Schwarza M., Burkholderb I., Kopp-Schneider A., Edlerb L., Kinsner-Ovaskainenc A., Hartungd T., Hoffmanne S. "ToxRTool", a new tool to assess the reliability of toxicological data. Toxicol. Lett. 2009, 189:138-144.
93. Schultz T.W. Adverse outcome pathways: a way of linking chemical structure to in vivo toxicological hazards. In Silico Toxicology: Principles and Applications 2010, The Royal Society of Chemistry, Cambridge. M.T.D. Cronin, J.C. Madden (Eds.).
94. Stranz D.D., Miao S., Campbell S., Maydwell G., Ekins S. Combined computational metabolite prediction and automated structure-based analysis of mass spectrometric data. Toxicol. Mech. Methods 2008, 18:243-250.
95. ten Berge W.F., Zwart A., Appelman L.M. Concentration-time mortality response relationship of irritant and systematically acting vapours and gases. J. Hazard. Mater. 1986, 13:301-309.
96. Veber D.F., Johnson S.R., Cheng H.Y., Smith B.R., Ward K.W., Kopple K.D. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 2002, 45:2615-2623.
97. Venkatapathy R., Moudgal C.J., Bruce R.M. Assessment of the oral rat chronic lowest observed adverse effect level model in TOPKAT, a QSAR software package for toxicity prediction. J. Chem. Inf. Comput. Sci. 2004, 44:1623-1629.
98. Venkatapathy R., Wang C.Y., Bruce R.M., Moudgal C. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals. I alternative toxicity measures as an estimator of carcinogenic potency. Toxicol. Appl. Pharmacol. 2009, 234:209-221.
99. Wang N.C., Venkatapathy R., Bruce R.M., Moudgal C. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals. II. Using oral slope factor as a measure of carcinogenic potency. Regul. Toxicol. Pharmacol. 2011, 59:215-226.
100. Wegner J.K., Fröhlich H., Zell A. Feature selection for descriptor based classification models. 2. Human intestinal absorption (HIA). J. Chem. Inf. Comput. Sci. 2004, 44(3):931-939.
101. Wessel M.D., Jurs P.C., Tolan J.W., Muskal S.M. Prediction of human intestinal absorption of drug compounds from molecular structure. J. Chem. Inf. Comput. Sci. 1998, 38:726-735.
102. Willet P. Similarity-based virtual screening using 2D fingerprints. Drug Discov. 2006, 11:23-24.
103. Willet P., Barnard J.M., Downs G.M. Chemical similarity searching. J. Chem. Inf. Comput. Sci. 1998, 38(6):983-996.
104. Woo Y.T., Lai D.Y. OncoLogic: a mechanism-based expert system for predicting the carcinogenic potential of chemicals. Predictive Toxicology 2005, 385-413. CRC Press, Boca Raton FL, USA. C. Helma (Ed.).
105. Wu S., Blackburn K., Amburgey J., Jaworska J., Federle T. A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments. Regul. Toxicol. Pharmacol. 2010, 56:67-81.
106. Yang C., Cross K., Myatt G.J., Blower P.E., Rathman J.F. Building predictive models for protein tyrosine phosphatase 1B inhibitors based on discriminating structural features by reassembling medicinal chemistry building blocks. J. Med. Chem. 2004, 47:5984-5994.
107. Young D., Martin T., Venkatapathy R., Harten P. Are the chemical structures in your QSAR correct?. QSAR Comb. Sci. 2008, 27:1337-1345.
108. Zhao Y.H., Le J., Abraham M.H., Hersey A., Eddershaw P.J., Luscombe C.N., Butina D., Beck G., Sherborne B., Cooper I., Platts J.A. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. J. Pharm. Sci. 2001, 90:749-784.
109. Zarn J.A., Hänggi E., Kuchen A., Schlatter J.R. The significance of the subchronic toxicity in the dietary risk assessment of pesticides. Regul. Toxicol. Pharmacol. 2010, 58(1):72-78.